Financials Sanofi India Limited

Equities

SANOFI

INE058A01010

Pharmaceuticals

Market Closed - Bombay S.E. 06:00:49 2024-04-29 am EDT 5-day change 1st Jan Change
8,282 INR +0.05% Intraday chart for Sanofi India Limited +0.30% +2.66%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 146,307 161,572 191,565 181,781 134,721 190,741 190,741 -
Enterprise Value (EV) 1 146,307 161,572 191,565 181,781 134,721 185,790 190,741 190,741
P/E ratio 38.4 x 39 x 40.1 x 19.2 x 21.7 x 30.8 x 29.7 x 26.4 x
Yield 1.32% 1.51% 4.39% 6.21% 9.74% 4.19% 2.17% 2.39%
Capitalization / Revenue 5.28 x 5.26 x 6.6 x 6.15 x 4.86 x 6.52 x 6.16 x 5.61 x
EV / Revenue 5.28 x 5.26 x 6.6 x 6.15 x 4.86 x 6.52 x 6.16 x 5.61 x
EV / EBITDA 23.5 x 24.3 x 26.9 x 23.8 x 19.1 x 23.1 x 21.5 x 19.3 x
EV / FCF 46.5 x 48 x 33.6 x 33.9 x 35.8 x 94.5 x 24.1 x 24.3 x
FCF Yield 2.15% 2.08% 2.97% 2.95% 2.79% 1.06% 4.14% 4.12%
Price to Book 6.58 x 6.61 x 9.03 x 8.16 x 10.5 x 18.3 x 15.2 x 12.5 x
Nbr of stocks (in thousands) 23,031 23,031 23,031 23,031 23,031 23,031 23,031 -
Reference price 2 6,353 7,016 8,318 7,893 5,850 8,282 8,282 8,282
Announcement Date 2/26/19 2/25/20 2/23/21 2/23/22 2/23/23 2/23/24 - -
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net sales 1 27,708 30,706 29,019 29,566 27,701 28,511 30,945 33,986
EBITDA 1 6,235 6,653 7,131 7,625 7,044 8,040 8,855 9,883
EBIT 1 5,208 5,654 6,309 6,958 6,625 7,644 8,456 9,484
Operating Margin 18.8% 18.41% 21.74% 23.53% 23.92% 26.81% 27.33% 27.9%
Earnings before Tax (EBT) 1 6,098 5,999 6,772 12,576 8,643 8,458 9,008 10,145
Net income 1 3,806 4,142 4,776 9,444 6,206 6,032 6,410 7,231
Net margin 13.74% 13.49% 16.46% 31.94% 22.4% 21.16% 20.72% 21.28%
EPS 2 165.5 179.8 207.4 410.1 269.5 261.9 278.4 314.1
Free Cash Flow 1 3,147 3,365 5,697 5,358 3,765 1,965 7,904 7,856
FCF margin 11.36% 10.96% 19.63% 18.12% 13.59% 6.89% 25.54% 23.12%
FCF Conversion (EBITDA) 50.47% 50.58% 79.89% 70.27% 53.45% 24.44% 89.27% 79.49%
FCF Conversion (Net income) 82.69% 81.24% 119.28% 56.73% 60.67% 32.58% 123.3% 108.65%
Dividend per Share 2 84.00 106.0 365.0 490.0 570.0 347.0 179.9 198.1
Announcement Date 2/26/19 2/25/20 2/23/21 2/23/22 2/23/23 2/23/24 - -
1INR in Million2INR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2020 Q3 2020 Q4 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1
Net sales 1 6,866 7,203 7,251 7,891 7,545 6,879 7,070 6,993 6,919 6,719 7,365 7,263 7,006 7,111 7,730
EBITDA 1 1,922 1,670 1,894 2,471 1,988 1,272 1,945 1,611 1,819 1,669 2,299 2,141 1,924 2,022 2,396
EBIT - - - - - - - - - - - - - - -
Operating Margin - - - - - - - - - - - - - - -
Earnings before Tax (EBT) - - - - - - - - - - - - - - -
Net income - 1,230 - 1,783 5,298 904 2,384 1,204 1,824 1,309 - 1,783 1,536 1,620 1,767
Net margin - 17.08% - 22.6% 70.22% 13.14% 33.72% 17.22% 26.36% 19.48% - 24.55% 21.92% 22.78% 22.86%
EPS - - - 77.42 - - - - 56.84 - - - - - -
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 10/27/20 2/23/21 4/27/21 7/27/21 10/26/21 2/23/22 4/26/22 7/26/22 11/3/22 2/23/23 5/10/23 - - - -
1INR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 3,147 3,365 5,697 5,358 3,765 1,965 7,904 7,856
ROE (net income / shareholders' equity) 17.9% 17.8% 20.9% 26.6% 30% 51.5% 54.9% 51.1%
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 2 965.0 1,062 921.0 968.0 555.0 442.0 546.0 662.0
Cash Flow per Share - - - - - - - -
Capex 1 592 758 414 230 222 343 744 627
Capex / Sales 2.14% 2.47% 1.43% 0.78% 0.8% 1.2% 2.4% 1.84%
Announcement Date 2/26/19 2/25/20 2/23/21 2/23/22 2/23/23 2/23/24 - -
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. SANOFI Stock
  4. Financials Sanofi India Limited